Insulin resistance is a characteristic feature of obesity and type 2 diabetes mellitus. The PPARgamma nuclear receptor is the target of Thiazolidinediones (TZD), a class of anti-diabetic drugs known to ameliorate insulin resistance. Despite the known action of TZDs to improve insulin sensitivity, many aspects of PPARgamma biology remain relatively unclear. In this application we plan to utilize gene knockout technology to elucidate the physiologic and cellular mechanisms of PPARgamma biology relating to insulin action and glucose homeostasis. Previous studies from our laboratory have shown that animals heterozygous for a PPAR gene deletion (PPARgamma+/-) demonstrate enhanced insulin sensitivity in muscle and liver. This led us to hypothesize that the PPARgamma receptor and its natural ligands normally serve to dampen insulin action. We believe that PPARgamma gene deletion releases this dampening effect leading to heightened insulin sensitivity. Since the PPARgamma+/-mice display enhanced insulin sensitivity, (1) we will test the hypothesis that when crossed into genetically insulin resistant animals, the insulin resistance phenotype will be rescued. While it is known that TZDs improve the ability of insulin to stimulate glucose disposal, the site of TZD action remains unknown. (2) To assess the differential role of PPARgamma receptor expression in fat vs. muscle, our laboratory has used the Cre-Lox system to create animals with a PPARgamma gene deletion in either skeletal muscle (MCK-Cre mice), or adipose tissue (aP2-Cre mice). The phenotype of these animals will be studied in vivo and in vitro, with or without perturbations including: a) TZD treatment and b) high fat feeding. In summary, in this application we propose to utilize the techniques of mouse genetics combined with a variety of in vivo and in vitro studies to elucidate the role of PPARgamma nuclear receptors in whole body, skeletal muscle, and adipose tissue metabolism. We feel that the findings from the proposed investigations will improve our general understanding of insulin resistance and offer potential insights into new therapeutic modalities.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
5K01DK060484-03
Application #
6682714
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Hyde, James F
Project Start
2002-02-15
Project End
2004-12-31
Budget Start
2004-01-01
Budget End
2004-12-31
Support Year
3
Fiscal Year
2004
Total Cost
$117,180
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Zhou, Zhenqi; Ribas, Vicent; Rajbhandari, Prashant et al. (2018) Estrogen receptor ? protects pancreatic ?-cells from apoptosis by preserving mitochondrial function and suppressing endoplasmic reticulum stress. J Biol Chem 293:4735-4751
Ribas, Vicent; Drew, Brian G; Zhou, Zhenqi et al. (2016) Skeletal muscle action of estrogen receptor ? is critical for the maintenance of mitochondrial function and metabolic homeostasis in females. Sci Transl Med 8:334ra54
Drew, Brian G; Hamidi, Habib; Zhou, Zhenqi et al. (2015) Estrogen receptor (ER)?-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression. J Biol Chem 290:5566-81
Ribas, Vicent; Drew, Brian G; Le, Jamie A et al. (2011) Myeloid-specific estrogen receptor alpha deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development. Proc Natl Acad Sci U S A 108:16457-62
Srikanthan, Preethi; Hevener, Andrea L; Karlamangla, Arun S (2010) Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS One 5:e10805
Ribas, Vicent; Nguyen, M T Audrey; Henstridge, Darren C et al. (2010) Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice. Am J Physiol Endocrinol Metab 298:E304-19
Yeh, Tsung-Yin J; Beiswenger, Kristina K; Li, Pingping et al. (2009) Hypermetabolism, hyperphagia, and reduced adiposity in tankyrase-deficient mice. Diabetes 58:2476-85
Crowe, Seamus; Wu, Lindsay E; Economou, Catherine et al. (2009) Pigment epithelium-derived factor contributes to insulin resistance in obesity. Cell Metab 10:40-7
Chung, Jason; Nguyen, Anh-Khoi; Henstridge, Darren C et al. (2008) HSP72 protects against obesity-induced insulin resistance. Proc Natl Acad Sci U S A 105:1739-44
Pascual, Gabriel; Ricote, Mercedes; Hevener, Andrea L (2007) Macrophage peroxisome proliferator activated receptor gamma as a therapeutic target to combat Type 2 diabetes. Expert Opin Ther Targets 11:1503-20

Showing the most recent 10 out of 19 publications